
Robert E. Mosser
Examiner (ID: 16617, Phone: (571)272-4451 , Office: P/3714 )
| Most Active Art Unit | 3715 |
| Art Unit(s) | 3714, 3715, 3713, 3712 |
| Total Applications | 839 |
| Issued Applications | 347 |
| Pending Applications | 141 |
| Abandoned Applications | 372 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6595758
[patent_doc_number] => 20100048573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'Methods of Inhibiting Bacterial Virulence and Compounds Relating Thereto'
[patent_app_type] => utility
[patent_app_number] => 12/254690
[patent_app_country] => US
[patent_app_date] => 2008-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 34893
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20100048573.pdf
[firstpage_image] =>[orig_patent_app_number] => 12254690
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/254690 | Methods of inhibiting bacterial virulence and compounds relating thereto | Oct 19, 2008 | Issued |
Array
(
[id] => 5285461
[patent_doc_number] => 20090099136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-16
[patent_title] => 'DIOXOLANE THYMINE PHOSPHORAMIDATES AS ANTI-HIV AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/251574
[patent_app_country] => US
[patent_app_date] => 2008-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21727
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20090099136.pdf
[firstpage_image] =>[orig_patent_app_number] => 12251574
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/251574 | DIOXOLANE THYMINE PHOSPHORAMIDATES AS ANTI-HIV AGENTS | Oct 14, 2008 | Abandoned |
Array
(
[id] => 6360060
[patent_doc_number] => 20100087469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-08
[patent_title] => 'Natural product derivatives with antimalarial activity'
[patent_app_type] => utility
[patent_app_number] => 12/287198
[patent_app_country] => US
[patent_app_date] => 2008-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5318
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20100087469.pdf
[firstpage_image] =>[orig_patent_app_number] => 12287198
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/287198 | Natural product derivatives with antimalarial activity | Oct 7, 2008 | Issued |
Array
(
[id] => 7795903
[patent_doc_number] => 08124609
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-02-28
[patent_title] => 'Acyclic nucleoside derivatives'
[patent_app_type] => utility
[patent_app_number] => 12/245553
[patent_app_country] => US
[patent_app_date] => 2008-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 19752
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/124/08124609.pdf
[firstpage_image] =>[orig_patent_app_number] => 12245553
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/245553 | Acyclic nucleoside derivatives | Oct 2, 2008 | Issued |
Array
(
[id] => 8875883
[patent_doc_number] => 08470849
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-25
[patent_title] => '7-azaindole derivatives as selective 11-β-hydroxysteroid dehydrogenase type 1 inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/741254
[patent_app_country] => US
[patent_app_date] => 2008-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16014
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12741254
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/741254 | 7-azaindole derivatives as selective 11-β-hydroxysteroid dehydrogenase type 1 inhibitors | Sep 30, 2008 | Issued |
Array
(
[id] => 5441827
[patent_doc_number] => 20090093466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-09
[patent_title] => 'Carboxamide GABAa ALPHA2 Modulators'
[patent_app_type] => utility
[patent_app_number] => 12/240237
[patent_app_country] => US
[patent_app_date] => 2008-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15822
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20090093466.pdf
[firstpage_image] =>[orig_patent_app_number] => 12240237
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/240237 | Carboxamide GABAA α2 modulators | Sep 28, 2008 | Issued |
Array
(
[id] => 5289956
[patent_doc_number] => 20090022686
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-22
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SYSTEMIC INFLAMMATORY RESPONSE SYNDROME'
[patent_app_type] => utility
[patent_app_number] => 12/238807
[patent_app_country] => US
[patent_app_date] => 2008-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11087
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20090022686.pdf
[firstpage_image] =>[orig_patent_app_number] => 12238807
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/238807 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SYSTEMIC INFLAMMATORY RESPONSE SYNDROME | Sep 25, 2008 | Abandoned |
Array
(
[id] => 10870400
[patent_doc_number] => 08895598
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-25
[patent_title] => 'Methods of treating a flaviviridae family viral infection, compositions for treating a flaviviridae family viral infection, and screening assays for identifying compositions for treating a flaviviridae family viral infection'
[patent_app_type] => utility
[patent_app_number] => 12/678014
[patent_app_country] => US
[patent_app_date] => 2008-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 20
[patent_no_of_words] => 43001
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12678014
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/678014 | Methods of treating a flaviviridae family viral infection, compositions for treating a flaviviridae family viral infection, and screening assays for identifying compositions for treating a flaviviridae family viral infection | Sep 17, 2008 | Issued |
Array
(
[id] => 10018541
[patent_doc_number] => 09061010
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-23
[patent_title] => 'Methods of treating a Flaviviridae family viral infection and compositions for treating a Flaviviridae family viral infection'
[patent_app_type] => utility
[patent_app_number] => 12/677989
[patent_app_country] => US
[patent_app_date] => 2008-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 20
[patent_no_of_words] => 36814
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12677989
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/677989 | Methods of treating a Flaviviridae family viral infection and compositions for treating a Flaviviridae family viral infection | Sep 17, 2008 | Issued |
Array
(
[id] => 8201201
[patent_doc_number] => 08188104
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-29
[patent_title] => 'Anti-infective agents and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/212323
[patent_app_country] => US
[patent_app_date] => 2008-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 23
[patent_no_of_words] => 87727
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/188/08188104.pdf
[firstpage_image] =>[orig_patent_app_number] => 12212323
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/212323 | Anti-infective agents and uses thereof | Sep 16, 2008 | Issued |
Array
(
[id] => 7687507
[patent_doc_number] => 20090176784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-09
[patent_title] => 'ANTI-INFECTIVE AGENTS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/212315
[patent_app_country] => US
[patent_app_date] => 2008-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 65510
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20090176784.pdf
[firstpage_image] =>[orig_patent_app_number] => 12212315
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/212315 | Anti-infective agents and uses thereof | Sep 16, 2008 | Issued |
Array
(
[id] => 5480798
[patent_doc_number] => 20090203755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'USE OF CRF1 RECEPTOR ANTAGONISTS FOR PREPARING A DRUG FOR TREATING METABOLIC SYNDROME AND/OR OBESITY AND/OR DYSLIPOPROTEINEMIA'
[patent_app_type] => utility
[patent_app_number] => 12/211147
[patent_app_country] => US
[patent_app_date] => 2008-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8645
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20090203755.pdf
[firstpage_image] =>[orig_patent_app_number] => 12211147
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/211147 | USE OF CRF1 RECEPTOR ANTAGONISTS FOR PREPARING A DRUG FOR TREATING METABOLIC SYNDROME AND/OR OBESITY AND/OR DYSLIPOPROTEINEMIA | Sep 15, 2008 | Abandoned |
Array
(
[id] => 5944857
[patent_doc_number] => 20110105477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'COMPOSITIONS AND METHODS RELATING TO HIV PROTEASE INHIBITION'
[patent_app_type] => utility
[patent_app_number] => 12/668980
[patent_app_country] => US
[patent_app_date] => 2008-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 15705
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20110105477.pdf
[firstpage_image] =>[orig_patent_app_number] => 12668980
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/668980 | COMPOSITIONS AND METHODS RELATING TO HIV PROTEASE INHIBITION | Sep 11, 2008 | Abandoned |
Array
(
[id] => 6350909
[patent_doc_number] => 20100249166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'DIFFERENTIAL EVAPORATION POTENTIATED DISINFECTANT SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 12/733709
[patent_app_country] => US
[patent_app_date] => 2008-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 9527
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20100249166.pdf
[firstpage_image] =>[orig_patent_app_number] => 12733709
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/733709 | DIFFERENTIAL EVAPORATION POTENTIATED DISINFECTANT SYSTEM | Sep 11, 2008 | Abandoned |
Array
(
[id] => 5954858
[patent_doc_number] => 20110034708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-10
[patent_title] => 'PHARMACEUTICAL COMPOSITION EFFECTIVE AGAINST BIOFILMS'
[patent_app_type] => utility
[patent_app_number] => 12/675561
[patent_app_country] => US
[patent_app_date] => 2008-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4006
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20110034708.pdf
[firstpage_image] =>[orig_patent_app_number] => 12675561
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/675561 | Pharmaceutical composition effective against biofilms | Sep 4, 2008 | Issued |
Array
(
[id] => 9469042
[patent_doc_number] => 08722674
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-13
[patent_title] => '1,3,5-triazine-2,4,6-triamine compound or pharmaceutical acceptable salt thereof, and pharmaceutical composition comprising the same'
[patent_app_type] => utility
[patent_app_number] => 12/674886
[patent_app_country] => US
[patent_app_date] => 2008-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8590
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12674886
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/674886 | 1,3,5-triazine-2,4,6-triamine compound or pharmaceutical acceptable salt thereof, and pharmaceutical composition comprising the same | Aug 27, 2008 | Issued |
Array
(
[id] => 8982307
[patent_doc_number] => 08513422
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-20
[patent_title] => 'Piperidine derivative'
[patent_app_type] => utility
[patent_app_number] => 12/675744
[patent_app_country] => US
[patent_app_date] => 2008-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11831
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12675744
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/675744 | Piperidine derivative | Aug 27, 2008 | Issued |
Array
(
[id] => 5539901
[patent_doc_number] => 20090221706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'Methods of treating cognitive dysfunction by modulating brain energy metabolism'
[patent_app_type] => utility
[patent_app_number] => 12/229716
[patent_app_country] => US
[patent_app_date] => 2008-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8720
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20090221706.pdf
[firstpage_image] =>[orig_patent_app_number] => 12229716
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/229716 | Methods of treating cognitive dysfunction by modulating brain energy metabolism | Aug 25, 2008 | Abandoned |
Array
(
[id] => 5354750
[patent_doc_number] => 20090186094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-23
[patent_title] => 'Injectable and Swellable Microspheres for Tissue Bulking'
[patent_app_type] => utility
[patent_app_number] => 12/197187
[patent_app_country] => US
[patent_app_date] => 2008-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9752
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20090186094.pdf
[firstpage_image] =>[orig_patent_app_number] => 12197187
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/197187 | Injectable and swellable microspheres for tissue bulking | Aug 21, 2008 | Issued |
Array
(
[id] => 9761799
[patent_doc_number] => 08846118
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-30
[patent_title] => 'Use of anabolic agents, anti-catabolic agents, antioxidant agents and analgesics for protection, treatment and repair of connective tissues in humans and animals'
[patent_app_type] => utility
[patent_app_number] => 12/230001
[patent_app_country] => US
[patent_app_date] => 2008-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9780
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12230001
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/230001 | Use of anabolic agents, anti-catabolic agents, antioxidant agents and analgesics for protection, treatment and repair of connective tissues in humans and animals | Aug 20, 2008 | Issued |